Target Selectivity of Inobrodib (CCS-1477)
| Key Target | IC50 | Description | Reference |
|---|---|---|---|
| p300 | 1.3 nM | KD values (acetylated lysine competitive bromodomain protein–protein interaction inhibition) | PMC11742294 |
| CBP | 1.7 nM | KD values (acetylated lysine competitive bromodomain protein–protein interaction inhibition) | PMC11742294 |
Check the
Inobrodib (CCS-1477)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Jump to
- Inobrodib (CCS-1477) Mechanism of Action: p300/CBP Inhibition in Plasma Cell Research
- Inobrodib (CCS-1477) Clinical Trials
- Inobrodib (CCS-1477) Working Concentration | Cell Culture | Treatment
- Inobrodib (CCS-1477) Solubility in DMSO
- Inobrodib (CCS-1477) Stock Solution
- Inobrodib (CCS-1477) Storage
- Inobrodib (CCS-1477) Stability
- Inobrodib (CCS-1477) Combination Database
- Inobrodib (CCS-1477) Molecular Weight
- Inobrodib (CCS-1477) SMILES
- Inobrodib (CCS-1477) CAS Number
- Inobrodib (CCS-1477) Chemical Structure (2D and 3D)
- Inobrodib (CCS-1477) IC50 for Cell-based and Cell-free Assays
- Inobrodib (CCS-1477) Sigma (AMBH9884BA72)? Try a better option.
- Inobrodib (CCS-1477) MedChemExpress (HY-111784)? Try a better option.
- Inobrodib (CCS-1477) Abmole (M21109)? Try a better option.
- Inobrodib (CCS-1477) Cayman (34546)? Try a better option.
- Inobrodib (CCS-1477) Tocris (8892)? Try a better option.
- Inobrodib (CCS-1477) SDS｜MSDS